Showing 6101-6110 of 20429 results for "".
- Advanced Genetic Testing Under Pressure: The Rising Tide of Claim Denials in Cancer Diagnosticshttps://reachmd.com/news/advanced-genetic-testing-trends-in-claim-denials-for-cancer-diagnostics/2474265/In recent years, next-generation sequencing (NGS) has emerged as a transformative tool in oncology, offering precision insights that shape diagnosis and treatment. But while the clinical value of these advanced genetic tests continues to grow, so too does the frict
- Moving Through the Cycle: How Exercise Eases Menstrual Discomforthttps://reachmd.com/news/menstrual-symptoms-the-role-of-exercise-habits/2474215/For many women, menstrual symptoms such as cramping, fatigue, and mood fluctuations are more than just a monthly inconvenience—they can significantly interfere with quality of life. While pharmacological therapies have long been the mainstay of symptom management,
- Combined Hind-Foot Alignment and Medial Arch Reconstruction in Pediatric Flexible Flatfoothttps://reachmd.com/news/combined-hind-foot-alignment-and-medial-arch-reconstruction-in-pediatric-flexible-flatfoot/2474249/In the realm of pediatric orthopedic surgery, a novel dual-intervention technique is showing promise for one of the most common—and often stubborn—foot conditions in children: flexible flatfoot. Drawing from recent case-series analyses, surgeons are now merging hind-
- The Role of 3D Gene Architecture in Glioblastomahttps://reachmd.com/news/the-role-of-3d-gene-architecture-in-glioblastoma/2474273/This article investigates the association between the three-dimensional folding of DNA within brain cells and glioblastoma. Leveraging preclinical research from Weill Cornell Medicine, it examines the impact of disruptions in 3D gene hubs on cellular functions.
- Hearing Loss and Dementia: Exploring the Link in Older Adultshttps://reachmd.com/news/hearing-loss-and-dementia-exploring-the-link-in-older-adults/2474287/As the global population ages, the rising prevalence of dementia has galvanized efforts to identify modifiable risk factors that could delay or prevent cognitive decline. One of the most promising yet underappreciated contributors to dementia risk is hearing loss. O
- Comprehensive Motion Management: MR-linac Applications in Prostate Cancer Radiotherapyhttps://reachmd.com/news/comprehensive-motion-management-mr-linac-applications-in-prostate-cancer-radiotherapy/2474278/Recent advancements in radiotherapy have introduced the 1.5T MR-linac, a novel device that merges magnetic resonance imaging with real-time radiation delivery. This dual-capability system represents a major stride toward precision medicine in prostate cancer care, allowing clinicians to visualize
- Clinical Data on Lumenis’ New Laser Hair Removal Solution to Be Presented at ASLMS Conferencehttps://reachmd.com/news/new-data-on-lumenis-new-laser-hair-removal-solution-to-be-presented-at-aslms-conference/2475349/Lumenis Be. Ltd. unveiled the newest edition of its breakthrough dual-wavelength laser hair removal solution, SPLENDOR XTM ahead of the American Society for Laser Medicine and Surgery (ASLMS) Conference. SPLENDOR XTM is powered by Lumenis’ proprietary BLEND X® tec
- AI Algorithm and Hypertrophic Cardiomyopathy: Enhanced Risk Stratification in Cardiologyhttps://reachmd.com/news/ai-algorithm-and-hypertrophic-cardiomyopathy-enhanced-risk-stratification-in-cardiology/2474276/Recent developments in artificial intelligence are transforming the landscape of hypertrophic cardiomyopathy management. By swiftly pinpointing high-risk individuals and seamlessly incorporating risk assessments into clinical routines, AI enables personalized and efficient
- Bliss Aesthetics Raises $17.5M to Launch AI-Powered Cosmetic Surgery Platformhttps://reachmd.com/news/bliss-aesthetics-raises-175m-to-launch-ai-powered-cosmetic-surgery-platform/2474271/Bliss Aesthetics, a digital platform that uses artificial intelligence (AI) to connect patients with board-certified plastic surgeons, announced a $17.5 million seed funding round. The investment, led by Shine Capital with participation from Synchrony Ventures, Sheva Ventures, Point72 Ve
- Clinical Data on Lumenis’ New Laser Hair Removal Solution Presented at ASLMS Conferencehttps://reachmd.com/news/clinical-data-on-lumenis-new-laser-hair-removal-solution-to-be-presented-at-aslms-conference/2474269/Lumenis Be. Ltd. unveiled the newest edition of its breakthrough dual-wavelength laser hair removal solution, SPLENDOR XTM ahead of the American Society for Laser Medicine and Surgery (ASLMS) Conference. SPLENDOR XTM is powered by Lumenis’ proprietary BLEND X® tec